in-house trial
XPRIZE Healthspan Update: Inside AgelessRx’s Longevity Clinical Trial
AgelessRx shares early XPRIZE Healthspan semifinal results and what they suggest about the future of personalized longevity medicine.
Inside the AgelessRx XPRIZE Trial
AgelessRx is an XPRIZE Healthspan semifinalist! Learn more about the AgelessRx XPRIZE trial and what this means for the future of aging.
AgelessRx Named Semi-Finalist in $101M XPRIZE Healthspan Global Competition
AgelessRx is a Semi-Finalist in the landmark XPRIZE Healthspan competition, a milestone that may propel longevity solutions to the spotlight.
AgelessRx Certified as an Official Vitalist Organization!
AgelessRx is now a Certified Vitalist Organization, advancing the longevity movement and fighting aging globally. Learn more about the certification and what it means for…
AgelessRx Donates to Support Biology of Aging Research
Learn about AgelessRx's gift to the Michigan Medicine Division of Geriatric and Palliative Medicine Geriatrics Center.
PEARL Webinar Series: A Must-Watch Outlining Our Clinical Study
Check out this video webinar series about a new AgelessRx sponsored study on the use of Rapamycin in longevity treatment.
A Quick Update on PEARL, AgelessRx’s Upcoming Clinical Trial
AgelessRx has started recruiting participants to our clinical trial PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity).
AgelessRx Launches Pilot Post-COVID Clinical Trial
Former ARX CMO Dr. Zalzala introduces new post-COVID-19 pilot study and shares how LDN and NAD+ may help with post-COVID-19 Syndrome.